Calcium in PDB 4i03: Human MMP12 in Complex with A Peg-Linked Bifunctional L-Glutamate Motif Inhibitor
Enzymatic activity of Human MMP12 in Complex with A Peg-Linked Bifunctional L-Glutamate Motif Inhibitor
All present enzymatic activity of Human MMP12 in Complex with A Peg-Linked Bifunctional L-Glutamate Motif Inhibitor:
3.4.24.65;
Protein crystallography data
The structure of Human MMP12 in Complex with A Peg-Linked Bifunctional L-Glutamate Motif Inhibitor, PDB code: 4i03
was solved by
E.A.Stura,
L.Vera,
L.Devel,
E.Cassar-Lajeunesse,
V.Dive,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
36.67 /
1.70
|
Space group
|
C 1 2 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
51.790,
60.100,
54.920,
90.00,
116.67,
90.00
|
R / Rfree (%)
|
14.4 /
19.4
|
Other elements in 4i03:
The structure of Human MMP12 in Complex with A Peg-Linked Bifunctional L-Glutamate Motif Inhibitor also contains other interesting chemical elements:
Calcium Binding Sites:
The binding sites of Calcium atom in the Human MMP12 in Complex with A Peg-Linked Bifunctional L-Glutamate Motif Inhibitor
(pdb code 4i03). This binding sites where shown within
5.0 Angstroms radius around Calcium atom.
In total 3 binding sites of Calcium where determined in the
Human MMP12 in Complex with A Peg-Linked Bifunctional L-Glutamate Motif Inhibitor, PDB code: 4i03:
Jump to Calcium binding site number:
1;
2;
3;
Calcium binding site 1 out
of 3 in 4i03
Go back to
Calcium Binding Sites List in 4i03
Calcium binding site 1 out
of 3 in the Human MMP12 in Complex with A Peg-Linked Bifunctional L-Glutamate Motif Inhibitor
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 1 of Human MMP12 in Complex with A Peg-Linked Bifunctional L-Glutamate Motif Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Ca303
b:23.3
occ:1.00
|
O
|
A:GLY192
|
2.2
|
17.2
|
1.0
|
O
|
A:ASP158
|
2.2
|
16.8
|
1.0
|
O
|
A:HOH414
|
2.3
|
28.7
|
1.0
|
O
|
A:GLY190
|
2.4
|
23.3
|
1.0
|
O
|
A:HOH419
|
2.5
|
20.4
|
1.0
|
OD1
|
A:ASP194
|
2.5
|
17.4
|
1.0
|
C
|
A:GLY192
|
3.4
|
15.1
|
1.0
|
C
|
A:ASP158
|
3.4
|
16.6
|
1.0
|
CG
|
A:ASP194
|
3.5
|
17.5
|
1.0
|
C
|
A:GLY190
|
3.6
|
22.4
|
1.0
|
O
|
A:HOH479
|
3.9
|
36.5
|
1.0
|
N
|
A:GLY192
|
3.9
|
17.8
|
1.0
|
C
|
A:ILE191
|
3.9
|
19.3
|
1.0
|
OD2
|
A:ASP194
|
4.0
|
18.2
|
1.0
|
O
|
A:ALA157
|
4.1
|
21.2
|
1.0
|
O
|
A:ILE191
|
4.1
|
18.2
|
1.0
|
CA
|
A:ASP158
|
4.2
|
17.1
|
1.0
|
CA
|
A:GLY192
|
4.2
|
16.7
|
1.0
|
N
|
A:ASP194
|
4.3
|
16.4
|
1.0
|
N
|
A:GLY193
|
4.3
|
17.4
|
1.0
|
N
|
A:ILE159
|
4.3
|
17.0
|
1.0
|
CA
|
A:ILE191
|
4.4
|
19.7
|
1.0
|
N
|
A:ILE191
|
4.4
|
20.9
|
1.0
|
O
|
A:GLY188
|
4.5
|
24.9
|
1.0
|
CA
|
A:GLY193
|
4.5
|
16.4
|
1.0
|
CA
|
A:ILE159
|
4.5
|
15.6
|
1.0
|
CA
|
A:GLY190
|
4.6
|
23.4
|
1.0
|
N
|
A:GLY190
|
4.6
|
24.6
|
1.0
|
N
|
A:LEU160
|
4.6
|
16.2
|
1.0
|
C
|
A:GLY193
|
4.7
|
16.6
|
1.0
|
CB
|
A:ASP194
|
4.7
|
14.0
|
1.0
|
O
|
A:HOH407
|
4.8
|
25.6
|
1.0
|
CA
|
A:ASP194
|
4.8
|
15.2
|
1.0
|
C
|
A:SER189
|
4.9
|
25.0
|
1.0
|
C
|
A:ALA157
|
5.0
|
20.3
|
1.0
|
|
Calcium binding site 2 out
of 3 in 4i03
Go back to
Calcium Binding Sites List in 4i03
Calcium binding site 2 out
of 3 in the Human MMP12 in Complex with A Peg-Linked Bifunctional L-Glutamate Motif Inhibitor
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 2 of Human MMP12 in Complex with A Peg-Linked Bifunctional L-Glutamate Motif Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Ca304
b:16.6
occ:1.00
|
OD2
|
A:ASP124
|
2.3
|
15.5
|
1.0
|
O
|
A:GLU199
|
2.3
|
15.4
|
1.0
|
OE2
|
A:GLU199
|
2.4
|
20.6
|
1.0
|
O
|
A:GLU201
|
2.5
|
15.7
|
1.0
|
O
|
A:HOH420
|
2.5
|
19.9
|
1.0
|
O
|
A:HOH429
|
2.5
|
23.6
|
1.0
|
OD1
|
A:ASP124
|
2.6
|
15.7
|
1.0
|
CG
|
A:ASP124
|
2.8
|
15.0
|
1.0
|
C
|
A:GLU199
|
3.4
|
16.1
|
1.0
|
CD
|
A:GLU199
|
3.5
|
16.3
|
1.0
|
C
|
A:GLU201
|
3.6
|
14.3
|
1.0
|
CG
|
A:GLU199
|
4.0
|
17.2
|
1.0
|
CA
|
A:GLU199
|
4.1
|
14.6
|
1.0
|
OG1
|
A:THR122
|
4.1
|
13.7
|
1.0
|
CA
|
A:PHE202
|
4.2
|
14.5
|
1.0
|
CB
|
A:ASP124
|
4.3
|
15.2
|
1.0
|
CD1
|
A:TRP203
|
4.3
|
16.9
|
1.0
|
N
|
A:PHE202
|
4.3
|
14.6
|
1.0
|
N
|
A:GLU201
|
4.4
|
15.3
|
1.0
|
C
|
A:ASP200
|
4.5
|
16.9
|
1.0
|
N
|
A:ASP200
|
4.5
|
15.6
|
1.0
|
OE1
|
A:GLU199
|
4.6
|
17.6
|
1.0
|
CB
|
A:GLU199
|
4.6
|
16.6
|
1.0
|
CA
|
A:GLU201
|
4.7
|
14.5
|
1.0
|
CA
|
A:ASP200
|
4.7
|
16.5
|
1.0
|
O
|
A:HOH410
|
4.7
|
47.6
|
1.0
|
O
|
A:HOH442
|
4.7
|
26.4
|
1.0
|
O
|
A:HOH490
|
4.8
|
42.7
|
1.0
|
N
|
A:TRP203
|
4.8
|
13.3
|
1.0
|
NE1
|
A:TRP203
|
4.8
|
16.8
|
1.0
|
CD1
|
A:PHE202
|
4.9
|
14.5
|
1.0
|
O
|
A:ASP200
|
5.0
|
18.2
|
1.0
|
|
Calcium binding site 3 out
of 3 in 4i03
Go back to
Calcium Binding Sites List in 4i03
Calcium binding site 3 out
of 3 in the Human MMP12 in Complex with A Peg-Linked Bifunctional L-Glutamate Motif Inhibitor
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 3 of Human MMP12 in Complex with A Peg-Linked Bifunctional L-Glutamate Motif Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Ca305
b:20.2
occ:1.00
|
OD2
|
A:ASP198
|
2.3
|
18.6
|
1.0
|
OD1
|
A:ASP175
|
2.3
|
22.0
|
1.0
|
OE2
|
A:GLU201
|
2.3
|
24.1
|
1.0
|
O
|
A:ILE180
|
2.3
|
24.4
|
1.0
|
O
|
A:GLY176
|
2.4
|
22.5
|
1.0
|
O
|
A:GLY178
|
2.4
|
27.1
|
1.0
|
CG
|
A:ASP198
|
3.4
|
18.0
|
1.0
|
C
|
A:ILE180
|
3.4
|
22.4
|
1.0
|
CG
|
A:ASP175
|
3.5
|
25.1
|
1.0
|
C
|
A:GLY178
|
3.5
|
27.6
|
1.0
|
CD
|
A:GLU201
|
3.5
|
23.9
|
1.0
|
C
|
A:GLY176
|
3.6
|
24.8
|
1.0
|
N
|
A:ILE180
|
3.7
|
25.1
|
1.0
|
N
|
A:GLY178
|
3.9
|
27.6
|
1.0
|
OD2
|
A:ASP175
|
4.0
|
23.0
|
1.0
|
CA
|
A:ILE180
|
4.0
|
25.2
|
1.0
|
CB
|
A:ASP198
|
4.1
|
13.3
|
1.0
|
N
|
A:GLY176
|
4.2
|
23.4
|
1.0
|
C
|
A:GLY179
|
4.2
|
26.7
|
1.0
|
C
|
A:LYS177
|
4.2
|
27.5
|
0.5
|
C
|
A:LYS177
|
4.2
|
27.4
|
0.5
|
CB
|
A:ILE180
|
4.3
|
24.0
|
1.0
|
CA
|
A:GLY178
|
4.3
|
28.0
|
1.0
|
CG
|
A:GLU201
|
4.3
|
19.9
|
1.0
|
C
|
A:ASP175
|
4.3
|
24.3
|
1.0
|
OD1
|
A:ASP198
|
4.4
|
17.0
|
1.0
|
OE1
|
A:GLU201
|
4.4
|
21.4
|
1.0
|
CA
|
A:LYS177
|
4.4
|
26.8
|
0.5
|
N
|
A:ASP175
|
4.4
|
21.3
|
1.0
|
CA
|
A:GLY176
|
4.4
|
24.0
|
1.0
|
N
|
A:LYS177
|
4.5
|
25.5
|
0.5
|
N
|
A:LYS177
|
4.5
|
25.6
|
0.5
|
CA
|
A:LYS177
|
4.5
|
27.0
|
0.5
|
N
|
A:GLY179
|
4.5
|
27.4
|
1.0
|
N
|
A:LEU181
|
4.5
|
20.2
|
1.0
|
CB
|
A:ASP175
|
4.7
|
22.7
|
1.0
|
CA
|
A:GLY179
|
4.7
|
28.4
|
1.0
|
CA
|
A:ASP175
|
4.7
|
22.8
|
1.0
|
O
|
A:ASP175
|
4.7
|
27.0
|
1.0
|
O
|
A:GLY179
|
4.8
|
27.1
|
1.0
|
O
|
A:LYS177
|
4.8
|
29.0
|
0.5
|
CA
|
A:LEU181
|
4.8
|
18.4
|
1.0
|
O
|
A:LYS177
|
4.9
|
28.9
|
0.5
|
|
Reference:
C.Antoni,
L.Vera,
L.Devel,
M.P.Catalani,
B.Czarny,
E.Cassar-Lajeunesse,
E.Nuti,
A.Rossello,
V.Dive,
E.A.Stura.
Crystallization of Bi-Functional Ligand Protein Complexes. J.Struct.Biol. V. 182 246 2013.
ISSN: ISSN 1047-8477
PubMed: 23567804
DOI: 10.1016/J.JSB.2013.03.015
Page generated: Sun Jul 14 07:57:12 2024
|